Toews Corporation’s Gilead Sciences GILD Stock Holding History

Toews Corporation’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,100	Closed	-$781K	–	59
2022 Q4	$781K	Sell	9,100 -9,200	-50%	-$729K	0.39%	39
2022 Q3	$1.13M	Sell	18,300 -2,100	-10%	-$132K	0.83%	19
2022 Q2	$1.26M	Buy	20,400 +13,600	+200%	+$842K	0.84%	13
2022 Q1	$404K	Buy	+6,800	New	+$435K	0.07%	70
2021 Q4	–	Sell	-5,900	Closed	-$412K	–	62
2021 Q3	$412K	Buy	+5,900	New	+$414K	0.05%	43
2021 Q2	–	Sell	-14,500	Closed	-$937K	–	61
2021 Q1	$937K	Buy	+14,500	New	+$935K	0.08%	82
2020 Q4	–	Sell	-15,400	Closed	-$973K	–	60
2020 Q3	$973K	Buy	+15,400	New	+$1.07M	0.29%	94

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Toews Corporation's GILD Position: Q1 2023 in Review

Toews Corporation sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 9,100 shares — an estimated $781K sold.

Toews Corporation first reported a position in GILD in Q3 2020 and held it in 7 quarters. The position peaked at $1.26M in Q2 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Toews Corporation reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Toews Corporation sold 9,100 Gilead Sciences shares in Q1 2023, an estimated $781K.
Toews Corporation first reported a position in Gilead Sciences in Q3 2020 and held it in 7 quarters.
Toews Corporation's Gilead Sciences position peaked at $1.26M in Q2 2022.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Toews Corporation's 13F filing for Q1 2023, filed 27 Apr 2023.